StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.82−0.03 (-1.05%)

Close on Nov 18, 2026Market cap $28.06MP/E –Yield –

Scynexis market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Scynexis's market cap was $33.98M on Nov 11, 2026, against $28.95M a year earlier. Over the last 5 years it ranged from $25.86M to $145.70M, with a median of $55.27M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$33.98M+28.1%
2025Dec 31, 2025$26.53M-42.2%
2024Dec 31, 2024$45.91M-44.6%
2023Dec 29, 2023$82.90M+62.7%
2022Dec 30, 2022$50.94M-65.0%
2021Dec 31, 2021$145.70M+76.4%
2020Dec 31, 2020$82.61M+58.2%
2019Dec 31, 2019$52.20M+129.6%
2018Dec 31, 2018$22.73M-65.4%
2017Dec 29, 2017$65.74M-12.0%
2016Dec 30, 2016$74.74M-13.4%
2015Dec 31, 2015$86.35M+1.7%
2014Dec 31, 2014$84.95M–

More Scynexis figures

See a number that looks wrong?